Biomedical Catalyst round 4: late stage award

Key Features

Small or medium-sized UK companies can apply for a share of up to £8 million to work on solving healthcare challenges in a clinical setting or a relevant late stage environment.

Programme:     Biomedical Catalyst

Award:     Up to £2.8m

Opens: 27th Nov 2017

Closes: 7th Feb 2018

! This scheme is now closed

This is a competition for a late stage award in the Biomedical Catalyst.

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The Biomedical Catalyst has 4 types of funding award. These are: feasibility, primer, early stage and late stage. They are designed to help SMEs developing a product or process to provide an innovative solution to a health and care challenge. The scheme supports progression from initial concept through to late stage development.

This is a competition for a late stage award.

The aim of this award is to support projects which test a well-developed concept and show its effectiveness in an environment that is relevant to the use of the product or process. A late stage project can include:

  • initial human proof-of-concept studies
  • demonstration of clinical utility and effectiveness
  • demonstration of safety and efficacy (including phase I and II clinical trials)
  • developing production mechanisms
  • prototyping
  • market testing
  • intellectual property protection

These solutions should be innovative healthcare technologies, products or processes that will help provide at least one of the following:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • treatments that either change underlying disease or offer potential cures

 

Projects from any sector or discipline will be supported, including (but not limited to):

  • advanced therapies (cell and gene therapy)
  • precision medicine (both therapy and
  • diagnostic components)
  • diagnostics
  • digital health
  • medical technologies and devices

If you choose the innovation area ‘Diagnostics, medical technology and devices’, you must indicate within the scope whether your project falls within ‘Diagnostics’ or ‘Medical technology and devices’.

The work required will depend on the maturity and intended application of the technology you are developing in your project. Your late stage project must build on prior credible research on your technology, product prototype or process. This prior research should include a demonstration or validation in an appropriate model system.

 

Eligibility 

To lead a project you must:

  • be a UK-based SME
  • work on your own or with other UK SMEs or research organisations
  • carry out your project work in the UK

Funding and project details

  • Projects to range in size from £200K to £4m
  • Projects should last 12 to 36 months.

Your project is expected to focus on industrial research. For this you could get up to 70% of your eligible project costs if you are an SME

For any work packages considered to be experimental development projects (nearer to market), you could get up to 45% of your eligible project costs if you are an SME.